Somatropin (rDNA origin) ( DrugBank: Somatropin )


1 disease
IDDisease name (Link within this page)Number of trials
78Hypopituitarism3

78. Hypopituitarism


Clinical trials : 494 Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02311894
(ClinicalTrials.gov)
March 31, 20154/12/2014A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone DeficiencyA Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naïve Growth Hormone-Deficient Children (iSTUDY)Growth Hormone DeficiencyDrug: SomatropinGenentech, Inc.NULLCompleted3 Years14 YearsAll82Phase 4United States
2NCT00600808
(ClinicalTrials.gov)
June 200323/7/2007Sustained Release Formulation of Somatropin (rDNA Origin)for InjectionA Phase II/IIIa, Assessor Blinded (Partially Blinded), Randomised, Active-Controlled, Multicentre, Parallel-Group Study of the Safety, Efficacy and pk/pd of LB03002 Administered Weekly in Children With Growth Failure Due to GH Deficiency.Growth Hormone DeficiencyDrug: BPLG-003BioPartners GmbHLG Life SciencesCompleted4 Years10 YearsBoth51Phase 2/Phase 3NULL
3NCT01088399
(ClinicalTrials.gov)
September 200225/2/2010A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient AdultsThe Global Hypopituitary Control and Complications StudyHypopituitarism;Pituitary Insufficiency;Growth Hormone Deficiency, AdultDrug: Somatropin (rDNA origin)Eli Lilly and CompanyNULLCompleted18 YearsN/AAll10673N/ANULL